In vivo gene therapies are a type of Advanced Therapy Medicinal Product. Many in vivo gene therapies use an adeno-associated vector (AAV) to deliver the genetically modified material into the cell. These shared care guidelines describe a typical pathway for an in vivo gene therapy utilising an AAV.
Shared care manual for in vivo gene therapy
Stuart Owen2021-12-21T17:00:13+00:0021st December 2021|